Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 342.00 | |
5 mg | In stock | $ 828.00 | |
25 mg | 8-10 weeks | $ 1,680.00 | |
50 mg | 8-10 weeks | $ 2,290.00 |
Description | GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis. |
Synonyms | GSK-2324, GSK 2324 |
Molecular Weight | 533.4 |
Formula | C29H22Cl2N2O4 |
CAS No. | 1020567-30-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK2324 1020567-30-9 Metabolism FXR GSK-2324 GSK 2324 inhibitor inhibit